These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2828959)
1. Inhibition of adenylate cyclase and induction of heterologous desensitization by kappa agonists in rat spinal cord. Attali B; Vogel Z NIDA Res Monogr; 1986; 75():141-4. PubMed ID: 2828959 [TBL] [Abstract][Full Text] [Related]
2. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. Attali B; Saya D; Vogel Z J Neurochem; 1989 Feb; 52(2):360-9. PubMed ID: 2536070 [TBL] [Abstract][Full Text] [Related]
3. Kappa opiate agonists inhibit Ca2+ influx in rat spinal cord-dorsal root ganglion cocultures. Involvement of a GTP-binding protein. Attali B; Saya D; Nah SY; Vogel Z J Biol Chem; 1989 Jan; 264(1):347-53. PubMed ID: 2535841 [TBL] [Abstract][Full Text] [Related]
4. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. Puttfarcken PS; Werling LL; Cox BM Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651 [TBL] [Abstract][Full Text] [Related]
5. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. Zeiders JL; Seidler FJ; Slotkin TA J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819 [TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures. Attali B; Saya D; Vogel Z NIDA Res Monogr; 1986; 75():434-7. PubMed ID: 2828988 [TBL] [Abstract][Full Text] [Related]
7. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. Duman RS; Tallman JF; Nestler EJ J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624 [TBL] [Abstract][Full Text] [Related]
8. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Murthy KS; Makhlouf GM Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832 [TBL] [Abstract][Full Text] [Related]
9. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Law PY; Hom DS; Loh HH Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114 [TBL] [Abstract][Full Text] [Related]
10. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. Prather PL; Tsai AW; Law PY J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314 [TBL] [Abstract][Full Text] [Related]
11. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits. Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820 [TBL] [Abstract][Full Text] [Related]
12. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells. Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233 [TBL] [Abstract][Full Text] [Related]
13. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Selley DE; Breivogel CS; Childers SR Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223 [TBL] [Abstract][Full Text] [Related]
14. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Carter BD; Medzihradsky F Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804 [TBL] [Abstract][Full Text] [Related]
15. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain. Chow T; Zukin RS Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362 [TBL] [Abstract][Full Text] [Related]
16. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
17. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. Schmauss C; Yaksh TL J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664 [TBL] [Abstract][Full Text] [Related]
18. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment. Attali B; Vogel Z Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432 [TBL] [Abstract][Full Text] [Related]
19. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. Cahill CM; White TD; Sawynok J J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600 [TBL] [Abstract][Full Text] [Related]
20. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide. Smith MM; Harden TK J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]